97 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
issuable upon the exercise of options or other equity awards pursuant to any employee or director share option, incentive or benefit plan, share … purchase or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award under rules of the Principal Market or other compensation
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
:
88,532,810 ordinary shares issuable upon exercise of outstanding awards under our equity incentive plans as of March 31, 2024; and
25,944,272 ordinary … that outstanding equity incentive awards or warrants are exercised or convertible notes converted, you will experience further dilution. In addition, we may choose
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
Incentive Plan (the "2019 EIP") and the 2019 Non-Employee Equity Incentive Plan (the “2019 NED EIP”). There are also still outstanding awards under
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
of all share incentive plans for approval by the Mereo Board and shareholders;
ensuring that contractual terms on termination of employment, and any … ;
at least annually, reviewing all incentive compensation arrangements for the purpose of assessing whether risks arising from the design or implementation
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
incentive to improve the Company’s performance. For these reasons, short sales of the Company’s securities are prohibited by this Policy. In addition
10-K
EX-97.1
yqo3atmapn2 udw0q
27 Mar 24
Annual report
5:20pm
10-K
hd0dlmbz vj
27 Mar 24
Annual report
5:20pm
S-8
EX-4.3
eup83db
23 Jan 24
Registration of securities for employees
4:16pm
S-8
33cdhf oxzi1w3
23 Jan 24
Registration of securities for employees
4:16pm
S-8
atda4knam7nnhb9 qo
23 Jan 24
Registration of securities for employees
4:16pm
S-8
EX-5.1
wt6y8u 3njhdgjhn7s
23 Jan 24
Registration of securities for employees
4:16pm
6-K
EX-99.1
cf77lg5
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.1
kc0c2qhrmaf3md0w4da
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.2
2o6tbm6ci naf7v3
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am